S. Hill (Birmingham, United Kingdom), A. Kroon-Beugelsdijk (Rotterdam, The Netherlands)
Applicability of adrenergic bronchodilatation test in a general population
S. Lehmann, S. E. Vollset, A. Gulsvik (Bergen, Norway)
|  |
Interindividual variability of peak inhalation rate through different inhalers by asthmatic children and adults and those with COPD
W. Tarsin, O. J. Corrado, K. Brownlee, P. Kanthapillai, S. Pearson, P. Chetcuti, H. Chrystyn (Bradford, Leeds, United Kingdom)
| |
Peak inspiratory flow in COPD: implications for the use of dry powder inhalers
J. A. Fonseca, J. C. Winck, E. Eusebio, P. Viana, J. Almeida, J. A. Marques (Porto, Portugal)
| |
Pharmaceutical performances of formoterol delivered from a novel multidose dry powder inhaler
X. M. Zeng, S. McKeon, S. Jones, J. Colledge (London, United Kingdom; Waterford, Ireland; Leiderdorp, The Netherlands)
| |
Delivery of a suspension corticosteroid formulation by small volume nebulizers: a comparative bench study
J. P. Mitchell, M. W. Nagel, K. J. Wiersema, S. L. Bates (London, Canada)
| |
Performance of a valved holding chamber with tracheostomy adapter: comparison with conventional valved holding chamber
J. P. Mitchell, M. W. Nagel, K. J. Wiersema, S. L. Bates, J. N. Schmidt (London, Canada)
| |
In vitro dosage emission for different flow rates from a combination of eformoterol and budesonide in a dry powder inhaler
W. Tarsin, K. H. Assi, H. Chrystyn (Bradford, United Kingdom)
| |
Assessment of bronchodilator reversibility in patients with bronchiectasis (BE)
J. A. Carter, S. L. Hill (Birmingham, United Kingdom)
| |
The evaluation of different factors that cause FEV1 decline in patients with COPD
L. V. Koukol, N. M. Kondrashova, S. A. Poupyshev (Atlanta, United States Of America; Vladivostok, Russia)
| |
Restrictive pulmonary disease in Italy
E. Battaglia, G. Garofalo, M. Bianchi, C. Castiglioni, S. Amaducci (Milan, Italy)
| |
Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis
D. Ionita, N. Bisca, S. Dutu, R. Nemes, G. Bistriceanu (Bucharest, Romania)
| |
Asthma control and small airways disease in a French epidemiological study: the JACINTE survey
Y. Martinat, Y. Rogeaux, K. Mezzi (Lyon, Villeneuve d'Ascq, Cergy, France)
| |
Bioacoustic of cough during bronchial inhalation challenge (BIC) with methacholine
F. Dalmasso, E. Isnardi, L. Sudaro, R. Bellantoni (Turin, Italy)
| |
Validation of the standard deviation of haematocrit as a measure of homogeneity of the sample in blood gas syringes
H. Normand, A. Leplingard, A. Mouadil (Caen, France)
| |
Transcutaneous oximetry (TCO) and pulse oximetry (PO) in diabetic foot (DF)
R. Scala, L. Ricci, I. Archinucci, M. Rossi (Arezzo, Italy)
| |
The measurement and diagnostic value of alveolo-capillary membrane permeability determined using pulmonary clearence of Tc99m-DTPA, in diffuse interstisial lung diseases
A. Erbaycu, A. Cakan, Z. Mutlu, A. Ozsoz, S. Dereli, H. Ozkilic (Yenisehir, Izmir, Turkey)
| |
Theoretical basis for carbon monoxide measurements in exhaled air
E. V. Babarskov, E. V. Stepanov, Y. A. Shulagin, A. V. Cherniak, Z. R. Aisanov, A. G. Chuchalin (Moscow, Russia)
| |
Monitoring of the β2-adrenergic effects in chronic obstructive pulmonary disease patients using an ultrasonic and a jet nebulizer
A. Dornelas de Andrade, N. F. Silva, L. O. A. Matos, B. R. S. Sanson, A. L. Gusmão, P. E. M. Marinho, C. C. M. M. B. De Castro, M. G. Rodrigues Machado (Recife, Brazil)
| |
Tidal expiratory airflow limitation before and after thyroidectomy in overweight patients with intrathoracic goiter
R. Torchio, C. Gulotta, C. Ciacco, A. Perboni, M. Guglielmo, G. Pancani, F. Orlandi, J. Milic-Emili (Orbassano, Torino, Italy; Montreal, Canada)
| |
Relationship between improvement in dyspnoea and change in lung function in obstructive lung disease
Z. Hall, H. K. Makker (London, United Kingdom)
| |